Cargando…

Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients

INTRODUCTION: Patients with rheumatoid arthritis (RA) treated with abatacept (ABT) are at increased risk for vaccine-preventable infections. The aim of the present study is to evaluate the humoral response to 23-valent pneumococcal polysaccharide (PPSV23) vaccination in RA patients receiving ABT. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Migita, Kiyoshi, Akeda, Yukihiro, Akazawa, Manabu, Tohma, Shigeto, Hirano, Fuminori, Ideguchi, Haruko, Kozuru, Hideko, Jiuchi, Yuka, Matsumura, Ryutaro, Suematsu, Eiichi, Miyamura, Tomoya, Mori, Shunsuke, Fukui, Takahiro, Izumi, Yasumori, Iwanaga, Nozomi, Tsutani, Hiroshi, Saisyo, Kouichirou, Yamanaka, Takao, Ohshima, Shiro, Mori, Naoya, Matsumori, Akinori, Takahi, Koichiro, Yoshizawa, Shigeru, Kawabe, Yojiro, Suenaga, Yasuo, Ozawa, Tetsuo, Hamada, Norikazu, Komiya, Yasuhiro, Matsui, Toshihiro, Furukawa, Hiroshi, Oishi, Kazunori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675027/ https://www.ncbi.nlm.nih.gov/pubmed/26653668 http://dx.doi.org/10.1186/s13075-015-0863-3

Ejemplares similares

The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial
por: Izumi, Yasumori, et al.
Publicado: (2017)

Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate
por: Migita, Kiyoshi, et al.
Publicado: (2015)

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
por: Migita, Kiyoshi, et al.
Publicado: (2015)

Predictors of Mortality in Patients With Interstitial Lung Disease Treated With Corticosteroids: Results from a Cohort Study
por: Migita, Kiyoshi, et al.
Publicado: (2014)

Sequential Administration of PCV13 Followed by PPSV23 Results in a More Robust Immune Response in PPSV23-Naïve Adults Age 60–64 Years
por: Chilson, Erica, et al.
Publicado: (2017)

Rates of Serious Intracellular Infections in Autoimmune Disease Patients Receiving Initial Glucocorticoid Therapy
por: Migita, Kiyoshi, et al.
Publicado: (2013)

Antibody responses after sequential vaccination with PCV13 and PPSV23 in kidney transplant recipients
por: Mülling, Nils, et al.
Publicado: (2023)

Serum Amyloid A Induces NLRP-3-Mediated IL-1β Secretion in Neutrophils
por: Migita, Kiyoshi, et al.
Publicado: (2014)

Reduced induction of anti-PF4/heparin antibody in RA patients after total knee arthroplasty
por: Izumi, Masahiro, et al.
Publicado: (2016)

1098 The Immunogenicity of PCV13 compared to PPSV23 in Immunocompetent Older Adults with Stable High Risk Conditions
por: Schmoele-Thoma, Beate, et al.
Publicado: (2014)

Factors associated with PPSV23 coverage among older adults in Japan: a nationwide community-based survey
por: Murakami, Yoshitaka, et al.
Publicado: (2019)

23-valent polysaccharide vaccine (PPSV23)-targeted serotype-specific identification of Streptococcus pneumoniae using the loop-mediated isothermal amplification (LAMP) method
por: Lee, Jiwon, et al.
Publicado: (2021)

Incidence of Symptomatic Vertebral Fractures Among Newly Diagnosed Autoimmune Diseases Initiating Glucocorticoid Therapy
por: Migita, Kiyoshi, et al.
Publicado: (2015)

Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Adults with and without Immunosuppressive Therapy
por: Garcia Garrido, Hannah M., et al.
Publicado: (2022)

A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) coverage among patients with chronic medical condition aged 50 and older
por: Kawakami, Kenji, et al.
Publicado: (2019)

Social capital and pneumococcal vaccination (PPSV23) in community-dwelling older Japanese: a JAGES multilevel cross-sectional study
por: Iwai-Saito, Kousuke, et al.
Publicado: (2021)

The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults
por: Feldman, Charles, et al.
Publicado: (2020)

A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) revaccination coverage rate among elderly adults aged 65 and older and physician’s attitude
por: Nakamura, Atsushi, et al.
Publicado: (2020)

Influenza, PCV13, and PPSV23 Vaccination Rates Among Inflammatory Bowel Disease Patients With Additional Co-Morbidities as per CDC Recommendations
por: Jordan, Ariel, et al.
Publicado: (2021)

Can PPSV-23 Vaccine Impact Exacerbations of Chronic Cough Symptoms and Medication Use in Younger Adult Asthmatics? A Clinical Question That Needs Answering
por: Lanz, Alessandra M., et al.
Publicado: (2022)

Effects of a Foot Pump on the Incidence of Deep Vein Thrombosis After Total Knee Arthroplasty in Patients Given Edoxaban: A Randomized Controlled Study
por: Sakai, Tatsuya, et al.
Publicado: (2016)

Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis
por: Temmoku, Jumpei, et al.
Publicado: (2022)

JAK inhibitors impair GM-CSF-mediated signaling in innate immune cells
por: Fujita, Yuya, et al.
Publicado: (2020)

Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus
por: Matsuoka, Naoki, et al.
Publicado: (2020)

CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes
por: Migita, Kiyoshi, et al.
Publicado: (2011)

Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumour progression and nm23 gene expression.
por: Mandai, M., et al.
Publicado: (1995)

Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils
por: Furuya, Makiko Yashiro, et al.
Publicado: (2018)

Expression of nm23‐Hl and nm23‐H2 Proteins in Prostate Carcinoma
por: Konishi, Noboru, et al.
Publicado: (1993)

Genetic risk factors for autoimmune hepatitis: implications for phenotypic heterogeneity and biomarkers for drug response
por: Higuchi, Takashi, et al.
Publicado: (2021)

Hydroxychloroquine inhibits IL-1β production from amyloid-stimulated human neutrophils
por: Fujita, Yuya, et al.
Publicado: (2019)

Sustained Long-Term Retention Rates of Abatacept in Combination with Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis
por: Sato, Shuzo, et al.
Publicado: (2021)

Fibroblast growth factor 23 (FGF23) level is associated with ultrafiltration rate in patients on hemodialysis
por: Nishizawa, Yoko, et al.
Publicado: (2020)

Inhibitory effects of the JAK inhibitor CP690,550 on human CD4(+ )T lymphocyte cytokine production
por: Migita, Kiyoshi, et al.
Publicado: (2011)

CERN Bulletin Issue No. 23-23/2020
Publicado: (2020)

Direct and indirect effects of fibroblast growth factor 23 on the heart
por: Nakano, Toshiaki, et al.
Publicado: (2023)

Biologic-free remission of established rheumatoid arthritis after discontinuation of abatacept: a prospective, multicentre, observational study in Japan
por: Takeuchi, Tsutomu, et al.
Publicado: (2015)

Abatacept in the treatment of rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2008)

Abatacept in the treatment of rheumatoid arthritis
por: Vital, Edward M, et al.
Publicado: (2006)

Abatacept treatment for rheumatoid arthritis
por: Schiff, Michael
Publicado: (2011)

Glucocorticoid Therapy and the Risk of Infection in Patients With Newly Diagnosed Autoimmune Disease
por: Migita, Kiyoshi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dkkhtagl2ej57ej22min1ucbe0